MVC effectively protects against graft-versus-host disease by blocking the recruitment of alloreactive donor T-cell responses [12,78–80] and improves lesions in a murine model of alopecia areata by impairing CD8+ T cell migration [49]. The gene discussed is CD8A; the disease is alopecia areata.